Sen. Lisa Boscola

Maddy summaryThis bill amends Pennsylvania's Wholesale Prescription Drug Distributors License Act to update definitions and application requirements for drug manufacturers. It clarifies the definition of a "virtual manufacturer" as a company that manufactures and distributes drugs without taking physical possession of the products within the state. The bill requires license applicants to disclose their FDA approval status or intent to submit an application within 12 months, while explicitly stating that FDA approval cannot be made a condition for licensure. These changes affect pharmaceutical companies operating in Pennsylvania and streamline the licensing process for manufacturers at various stages of FDA approval.

Maddy summaryThis bill amends Pennsylvania's tax code to update rules for the historic preservation incentive tax credit program. It expands the definition of eligible taxpayers to include various business entities and tax-exempt organizations that own historic structures. The legislation also increases the maximum annual tax credit amount a single applicant can receive from $500,000 to $1.5 million while setting a new statewide annual cap of $20 million. Additionally, it requires the Department of Community and Economic Development to distribute these credits equitably across different regions of the state.

Maddy summaryThis bill updates Pennsylvania's Home Improvement Consumer Protection Act to clarify who must register as a contractor and what work counts as home improvement. It expands the definition of a contractor to include independent workers hired by large retailers and raises the monetary threshold for required registration from $500 to $1,000. The legislation also adjusts the net worth threshold for exempt large retailers from $50 million to $50 million and adds specific exclusions for certain landscaping services and commercial conversions. Additionally, the bill introduces new requirements for out-of-state contractors to provide proof of good standing from their home jurisdictions.

Maddy summarySB 535 amends Pennsylvania's Osteopathic Medical Practice Act to clarify the role of genetic counselors. It adds a definition for "genetic test" (including DNA/RNA analysis and chromosome studies) and specifies that genetic counselors may order such tests, provide documentation, and coordinate care - but cannot diagnose, test, manage, or treat genetic conditions. The bill directly affects genetic counselors practicing within Pennsylvania's osteopathic medical framework. These changes aim to standardize terminology and practice boundaries without altering the scope of other medical professionals.

Maddy summaryThis bill amends Pennsylvania's Medical Practice Act to clarify the role of genetic counselors. It adds a definition for "genetic test" (covering DNA/RNA analysis, biochemical tests, and chromosome studies) and specifies that genetic counselors may order these tests, coordinate care, and document medical information for clients' records. Crucially, the bill explicitly states genetic counselors cannot diagnose, test for, manage, or treat genetic conditions. The changes directly affect licensed genetic counselors practicing in Pennsylvania, defining their scope within the state's medical licensing framework. The bill takes effect 60 days after enactment.

Maddy summaryThis bill establishes a new paid family and medical leave program in Pennsylvania, creating a fund to support workers who need time off for family care or medical reasons. It requires employers to contribute to the program and sets rules for how long employees can take leave, how much money they receive, and what situations qualify for benefits, including care for family members with serious health conditions or recovery from domestic violence. The Department of Labor and Industry will administer the program, handle claims, and enforce rules, while employees have the right to take legal action if their rights are violated. The legislation also includes provisions for self-employed individuals to opt into the program and establishes an advisory board to guide program development.

Maddy summarySB 806 amends Pennsylvania's Unfair Trade Practices and Consumer Protection Law to require businesses and creators to clearly disclose when content (such as text, images, audio, or video) is generated by artificial intelligence before presenting it to consumers. The bill defines "clear and conspicuous" disclosure as requiring the notice to be easily noticeable in size, color, location, and duration - without being hidden, contradicted, or obscured by other information. This applies to all AI-generated content distributed to consumers, including online posts, ads, or product descriptions. The law takes effect 60 days after enactment.

Maddy summaryThis resolution formally recognizes June 19, 2026, as "Juneteenth National Freedom Day" within the state of Pennsylvania. The measure serves a commemorative purpose by acknowledging the historical significance of the date, which marks the day enslaved people in Texas learned of their freedom in 1865. It does not alter laws or create new policies but instead establishes an official state recognition of this African-American holiday.

Maddy summaryThis Senate resolution honors the life of former State Senator Jack McGregor and expresses condolences following his death on January 6, 2026. The document outlines his extensive career, including his service in the Marine Corps, his tenure in the Pennsylvania Senate, and his role as a founder of the Pittsburgh Penguins. It also notes his various appointments to federal boards and his establishment of a scholarship at the University of Pittsburgh. The resolution serves as a formal acknowledgment of his public service and personal achievements rather than proposing new laws or policies.

Maddy summaryThis bill amends Pennsylvania's Workers' Compensation Act to update how pharmacies are reimbursed for compounded and topical medications. It directly affects employers, employees, and pharmacies by setting specific payment rules for custom-made drugs and topical treatments. The key provisions establish a $20 fee per prescription for compounded drugs with a $400 maximum per month, while non-compounded topical drugs are capped at $240 per month plus a $10 dispensing fee. The bill also clarifies definitions for compounded and topical drugs, noting that duplicates of commercially available medications are not reimbursable. These changes take effect 60 days after the bill is enacted.